Crescent Grove Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$495K Sell
1,190
-162
-12% -$60K 0.04% 186
2026
Q1
$366K Buy
1,352
+88
+7% +$26.2K 0.04% 208
2025
Q4
$417K Buy
1,264
+2
+0.2% +$678 0.04% 196
2025
Q3
$436K Hold
1,262
– – 0.04% 185
2025
Q2
$394K Sell
1,262
-19
-1% -$7.26K 0.04% 185
2025
Q1
$671K Buy
1,281
+30
+2% +$15.3K 0.07% 138
2024
Q4
$633K Buy
1,251
+65
+5% +$36.9K 0.06% 145
2024
Q3
$694K Sell
1,186
-116
-9% -$65.6K 0.07% 140
2024
Q2
$663K Sell
1,302
-2,399
-65% -$1.18M 0.07% 141
2024
Q1
$1.83M Buy
3,701
+1
+0% +$508 0.19% 78
2023
Q4
$1.95M Sell
3,700
-77
-2% -$41.1K 0.22% 68
2023
Q3
$1.9M Sell
3,777
-372
-9% -$183K 0.24% 70
2023
Q2
$1.99M Sell
4,149
-89
-2% -$43.5K 0.21% 69
2023
Q1
$2M Buy
4,238
+9
+0.2% +$4.34K 0.23% 64
2022
Q4
$2.24M Buy
4,229
+308
+8% +$163K 0.23% 65
2022
Q3
$1.98M Sell
3,921
-341
-8% -$179K 0.23% 57
2022
Q2
$2.19M Buy
4,262
+381
+10% +$191K 0.23% 56
2022
Q1
$1.98M Sell
3,881
-222
-5% -$107K 0.19% 62
2021
Q4
$2.06M Buy
4,103
+2,858
+230% +$1.29M 0.19% 62
2021
Q3
$486K Hold
1,245
– – 0.05% 158
2021
Q2
$499K Buy
+1,245
New +$496K 0.05% 152
2020
Q4
– Sell
-690
Closed -$215K – 187
2020
Q3
$215K Hold
690
– – 0.04% 155
2020
Q2
$204K Buy
+690
New +$198K 0.04% 142
2019
Q3
– Sell
-1,289
Closed -$315K – 164
2019
Q2
$315K Buy
+1,289
New +$310K 0.06% 119
2019
Q1
– Sell
-1,496
Closed -$373K – 168
2018
Q4
$373K Buy
+1,496
New +$395K 0.08% 108

Other funds holding UNH

Crescent Grove Advisors's UNH Position: Q2 2026 in Review

Crescent Grove Advisors reduced its UnitedHealth (UNH) stake by 12% in Q2 2026, selling an estimated $60K and leaving 1,190 shares worth $495K. The position accounts for 0.04% of the portfolio, ranked #186.

Crescent Grove Advisors first reported a position in UNH in Q4 2018 and has held it in 25 quarters since. The position peaked at $2.24M in Q4 2022. 3,394 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Crescent Grove Advisors held 1,190 shares of UnitedHealth worth $495K as of Q2 2026.
  • Crescent Grove Advisors sold 162 UnitedHealth shares in Q2 2026, an estimated $60K.
  • UnitedHealth made up 0.04% of Crescent Grove Advisors's portfolio in Q2 2026, its #186 holding.
  • Crescent Grove Advisors first reported a position in UnitedHealth in Q4 2018 and has held it in 25 quarters since.
  • Crescent Grove Advisors's UnitedHealth position peaked at $2.24M in Q4 2022.
  • 3,394 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.